Presence of SCC (adjusted OR = 7.02), PD-L1 expression of pre-NCIO (adjusted OR = 5.35), and tumor regression rate (adjusted OR = 8.45) were independently associated with MPR (all P < 0.05) (Table 6). The gene discussed is CD274; the disease is neoplasm.